U.S. patent application number 12/437097 was filed with the patent office on 2009-08-27 for medical devices.
This patent application is currently assigned to BOSTON SCIENTIFIC SCIMED, INC.. Invention is credited to Matthew Cambronne, Jonathan S. Stinson.
Application Number | 20090214373 12/437097 |
Document ID | / |
Family ID | 37216086 |
Filed Date | 2009-08-27 |
United States Patent
Application |
20090214373 |
Kind Code |
A1 |
Stinson; Jonathan S. ; et
al. |
August 27, 2009 |
Medical Devices
Abstract
Endoprostheses including composites, and methods of making the
endoprosthesis, are disclosed. The composites include at least a
first material and a second material having different chemical
compositions from each other.
Inventors: |
Stinson; Jonathan S.;
(Plymouth, MN) ; Cambronne; Matthew; (Mounds View,
MN) |
Correspondence
Address: |
FISH & RICHARDSON PC
P.O. BOX 1022
MINNEAPOLIS
MN
55440-1022
US
|
Assignee: |
BOSTON SCIENTIFIC SCIMED,
INC.
Maple Grove
MN
|
Family ID: |
37216086 |
Appl. No.: |
12/437097 |
Filed: |
May 7, 2009 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
11140401 |
May 27, 2005 |
|
|
|
12437097 |
|
|
|
|
Current U.S.
Class: |
419/8 ; 164/76.1;
164/98; 419/66 |
Current CPC
Class: |
A61F 2002/91533
20130101; A61F 2250/0032 20130101; A61F 2210/0076 20130101; A61F
2250/0015 20130101; A61F 2/915 20130101; A61F 2002/91575 20130101;
A61F 2230/0054 20130101; A61F 2/90 20130101; A61F 2220/0058
20130101; A61F 2250/0018 20130101; A61F 2002/91525 20130101; A61F
2002/072 20130101; A61F 2/91 20130101; A61L 31/12 20130101; A61F
2/07 20130101 |
Class at
Publication: |
419/8 ; 419/66;
164/98; 164/76.1 |
International
Class: |
B22F 7/04 20060101
B22F007/04; B22F 3/02 20060101 B22F003/02; B22D 19/16 20060101
B22D019/16; B22D 23/00 20060101 B22D023/00 |
Claims
1-37. (canceled)
38. A method of making an endoprosthesis, the method comprising:
introducing a powdered second material into at least some
interconnected channels defined by interconnected portions of a
first structure comprising a first material to form a dry
composite, the first and second materials having different chemical
compositions, consolidating the dry composite under pressure, and
using the consolidated composite to form at least a portion of the
endoprosthesis.
39. (canceled)
40. The method of claim 38, further comprising agitating the first
structure to distribute the powdered second material.
41. (canceled)
42. (canceled)
43. The method of claim 38, wherein the step of consolidating is
performed by cold pressing, sintering, or hot isostatic
pressing.
44. The method of claim 56, wherein the second material is molten
when introduced into at least some of the interconnected channels
in the first structure.
45. The method of claim 44, wherein the second material has a lower
melting temperature than the first structure.
46. The method of claim 44, further comprising melting the second
material by vacuum induction skull method prior to introducing it
into at least some of the interconnected channels in the first
structure.
47. The method of claim 44, wherein the second material comprises
titanium and the first structure comprises tantalum.
48. The method of claim 44, wherein the first structure is placed
in a mold and molten second material is introduced into the
mold.
49. (canceled)
50. The method of claim 38, further comprising creating the first
structure by introducing a molten first material into a mold having
a ceramic core in the form of the interconnected channels and
allowing the first material to harden, wherein the ceramic core
extends to at least one edge of the mold; removing the ceramic core
to leave the interconnected channels in the hardened first
material.
51. (canceled)
52. (canceled)
53. (canceled)
54. (canceled)
55. (canceled)
56. A method of making an endoprosthesis, the method comprising:
introducing a second material into at least some interconnected
channels defined by interconnected portions of a first structure
comprising a first material to form a composite, the first and
second materials having different chemical compositions, densifying
the composite into a billet; and shaping the billet to form at
least a portion of the endoprosthesis.
57. The method of claim 56, wherein the composite is densified by
applying heat and isostatic pressure to the composite.
58. The method of claim 56 wherein shaping the billet to form at
least a portion of the endoprosthesis comprises hot pressing, hot
extruding or forging the billet to form a rod, gun drilling the
rod, drawing the drilled rod into tubing and laser cutting the
tubing to form the endoprosthesis.
59. The method of claim 58, further comprising coating the
endoprosthesis with a biocompatible material.
60. The method of claim 38, wherein second material is introduced
into at least 50% of the interconnected portions of the first
structure.
61. The method of claim 38, wherein the first structure is selected
from the group consisting of a wire weave mesh, a braided wire, and
a tangled wire.
62. The method of claim 38, wherein the first structure is a
honeycomb.
63. The method of claim 38, wherein forming the consolidated
composite into at least a portion of the endoprosthesis comprises
drawing the consolidated composite into a tube.
64. A method of making an endoprosthesis, the method comprising:
introducing a second material comprising titanium into at least
some interconnected channels defined by interconnected portions of
a first structure comprising tantalum to form a composite, and
using the composite to form at least a portion of the
endoprosthesis.
65. The method of claim 64, wherein the first structure comprises
foamed tantalum.
Description
TECHNICAL FIELD
[0001] The invention relates to medical devices, such as
endoprostheses (e.g., stents).
BACKGROUND
[0002] The body includes various passageways such as arteries,
other blood vessels, and other body lumens. These passageways
sometimes become occluded or weakened. For example, the passageways
can be occluded by a tumor, restricted by plaque, or weakened by an
aneurysm. When this occurs, the passageway can be reopened or
reinforced, or even replaced, with a medical endoprosthesis. An
endoprosthesis is typically a tubular member that is placed in a
lumen in the body. Examples of endoprostheses include stents,
covered stents, and stent-grafts.
[0003] Endoprostheses can be delivered inside the body by a
catheter that supports the endoprosthesis in a compacted or
reduced-size form as the endoprosthesis is transported to a desired
site. Upon reaching the site, the endoprosthesis is expanded, for
example, so that it can contact the walls of the lumen.
[0004] The expansion mechanism may include forcing the
endoprosthesis to expand radially. For example, the expansion
mechanism can include the catheter carrying a balloon, which
carries a balloon-expandable endoprosthesis. The balloon can be
inflated to deform and to fix the expanded endoprosthesis at a
predetermined position in contact with the lumen wall. The balloon
can then be deflated, and the catheter withdrawn.
[0005] In another delivery technique, the endoprosthesis is formed
of an elastic material that can be reversibly compacted and
expanded, e.g., elastically or through a material phase transition.
During introduction into the body, the endoprosthesis is restrained
in a compacted condition. Upon reaching the desired implantation
site, the restraint is removed, for example, by retracting a
restraining device such as an outer sheath, enabling the
endoprosthesis to self-expand by its own internal elastic restoring
force.
[0006] When the endoprosthesis is advanced through the body, its
progress can be monitored, e.g., tracked, so that the
endoprosthesis can be delivered properly to a target site. After
the endoprosthesis is delivered to the target site, the
endoprosthesis can be monitored to determine whether it has been
placed properly and/or is functioning properly. Methods of
monitoring a medical device include X-ray fluoroscopy, computed
tomography (CT), and magnetic resonance imaging (MRI).
SUMMARY
[0007] Aspects of the invention feature medical devices including
endoprostheses (e.g., stents, grafts, stent grafts and the like),
and methods of making the medical devices. In one aspect,
endoprostheses are provided that are made up, at least in part, of
a composite. The composite includes a first structure having a
first material and having interconnected portions that define
interconnected channels. A second material is in at least some of
the interconnected channels. The first material and second material
have different chemical compositions.
[0008] In another aspect, endoprostheses are featured having a
first portion and a second portion. The endoprostheses include a
composite having a first structure that includes a first material
and that has interconnected portions that define interconnected
channels. The first structure has portions that extend into both
the first portion of the endoprosthesis and the second portion of
the endoprosthesis. A second material having a different chemical
composition than the first material is in at least some of the
interconnected channels of the portion of the first structure that
extends into the first portion of the endoprosthesis.
[0009] Embodiments may include one or more of the following
features.
[0010] The first material and the second material may differ from
each other in at least one material characteristic (e.g., density,
mass absorption coefficient, yield strength, % elongation, modulus)
which may affect at least one endoprosthesis parameter (e.g.,
radiopacity, magnetic susceptibility, expansion pressure,
compression strength, axial flexibility, radial stiffness). The
first and second materials each may impart different properties to
the endoprosthesis. The first material and/or the second material
may include a metal or an alloy. One or both of the first material
and second material may include a biodegradable or biostable
polymer. One or both of the first material and second material may
include a high strength material, e.g., iron and alloys thereof
(for example, stainless steel), cobalt and alloys thereof, titanium
and alloys thereof, and nickel and alloys thereof. One or both of
the first material and second material may include a radiopaque
material, e.g., tantalum, rhenium, indium, platinum, gold, silver,
iridium, niobium, molybdenum, and alloys of any of these. One or
both of the first material and second material may include
molybdenum, tungsten, chromium, tantalum over carbon Trabecular
Metal.TM. foam, and niobium over carbon Trabecular Metal.TM. foam.
One or both of the first material and second material may include
316L stainless steel, L605, MP35N.RTM. alloy, Elgiloy.RTM.,
platinum enhanced radiopaque stainless steel (PERSS), Nb-1Zr,
Nioballoy, NiTi, Biodur.RTM. 108 stainless steel, zirconium, an
alloy of zirconium, titanium, an alloy of titanium, biostable
polymer and bioabsorbable polymer.
[0011] The channels may have the form of pores or hollow
passageways, and may have a regular or an irregular cross-section.
The channels may be between about 10 microns and about 10 mm in
diameter at their narrowest part. At least about 50% (e.g., at
least about 75%) of the channels defined by the interconnected
portions of the first structure may be interconnected.
Substantially all of the channels defined by the interconnected
portions of the first structure may be connected to at least one
channel that is open to the exterior of the first structure.
Between about 10% and about 90% (e.g., between about 50% and about
90%) of the total volume of the first structure may comprise
channels.
[0012] The first structure may have solid and hollow portions where
the solid portions may be a continuous or discontinuous framework
formed of metal and/or polymer and the hollow portions may include
pores, channels, gaps, voids, and/or open areas. The first
structure may be in the form of, e.g., a foam, a wire weave mesh, a
plasma-sprayed deposit, a braided wire, a tangled wire, a honeycomb
or any combinations thereof. The first structure may have a width,
e.g., a maximum width, that is less than, e.g., between 5% and 90%
of, the width or thickness of a wall of the endoprosthesis (e.g.,
of the width or thickness of a strut of the endoprosthesis).
[0013] The first structure may be partially or substantially
encapsulated by the second material or by a combination of second
material and additional materials (e.g., third material, fourth
material, etc.). The second material may be bonded to the first
structure, e.g., mechanically bonded, adhesively bonded, and/or
metallurgically bonded. The endoprosthesis may be a stent or a
stent graft.
[0014] The first portion of the endoprosthesis may be disposed
inwardly relative to the second portion of the endoprosthesis
(e.g., the first portion may face the interior of the
endoprosthesis and the second portion may face the exterior of the
endoprosthesis). The composite may further include a third material
in at least some of the interconnected channels of the portion of
the first structure that extends into the second portion of the
endoprosthesis. The first material, second material and third
material may have chemical compositions different from each other.
The second material may have poor solid solubility with the third
material, that is to say, the second and third materials may be
incapable of or poorly capable of metallurgically bonding to one
another, such that the endoprosthesis may risk delamination absent
the first structure.
[0015] In another aspect, methods of making endoprosthesis in
accordance with any of those described above are provided. The
methods include forming a composite by introducing a second
material into at least some interconnected channels defined by
interconnected portions of a first structure, where the first
structure includes a first material having a different chemical
composition than the second material. The composite is used to form
at least a portion of the endoprosthesis.
[0016] Embodiments may include one or more of the following
features.
[0017] Second material in powdered form may be introduced into at
least some of the interconnected channels in the first structure to
form a dry composite, which may be consolidated in to a composite
under pressure, e.g., cold pressing, sintering or hot isostatic
pressure. The first structure may be agitated, e.g., by shaking,
vibrating or centrifugally rotating the first structure, which may
assist in distribution of the powered second material.
[0018] Second material in molten form may be introduced into at
least some of the channels in the first structure. The second
material may have a lower melting temperature than the first
structure, e.g., the second material may be titanium and the first
structure may be made of talantum. The second material may be
melted by vacuum induction skull method. The first structure may be
placed in a mold and molten second material may be introduced into
the mold. The first structure may be agitated, e.g., by shaking,
vibrating or centrifugally rotating the first structure, which may
assist in distribution of the molten second material
[0019] A mold having hollow passages in the shape of the first
structure may be formed out of second material, and first material,
e.g., molten or powdered first material, may be introduced into the
hollow passages. The mold may be agitated, e.g., by shaking,
vibrating or centrifugally rotating the mold, which may assist in
distribution of the first material. The mold may be formed by
introducing molten second material into a mold having a removable
core, e.g., a ceramic core, in the form of the first structure and
extending to at least one edge of the mold; allowing the second
material to harden removing the removable core to leave hollow
passages in the hardened second material; and introducing molten
first material into the hollow passages in the hardened second
material. The removable core may be removed by leaching, ashing, or
other suitable means.
[0020] The first structure may be made in the form of a mat having
interconnected channels that is then overlayed with and bonded to a
layer of second material, e.g. by annealing or diffusion bonding.
The mat may be overlayed with and bonded to a layer of third
material, for example, on an opposite face of the mat from the
layer of second material or at a region of the mat not overlayed
with second material. The third material may have a different
chemical composition than the second material.
[0021] The composite may be densified into a billet, e.g., through
the application of heat and isostatic pressure. The billet may be
further processed to form the endoprosthesis. For example, the
billet can be hot pressed, hot extruded or forged (e.g., gyratory
forging machine (GFM) forged, press forged, closed-die forged) to
form a rod, which may be hollowed, e.g., gun drilled, and drawn
into stent tubing. The stent tubing may be laser cut to form a
stent. The cut affected areas may be removed, and the stent may be
finished, e.g., finely polished. A biocompatible coating may be
applied to the endoprosthesis, e.g., coated on the interior surface
of the endoprosthesis, exterior surface of the endoprosthesis, or
over the entirety of the endoprosthesis.
[0022] Embodiments may include one or more of the following
advantages.
[0023] The endoprosthesis components may be selected to provide the
endoprosthesis with desirable characteristics, e.g., mechanical or
physical characteristics, that may not be available from an
endoprosthesis made up of a single material rather than a
composite. For example, while it is often desirable for an
endoprosthesis to have both high strength and sufficient
radiopacity to be readily observable by a physician, e.g., during
implantation, many radiopaque agents have limited solid solubility
in high strength alloys. Use of composites disclosed herein may
allow for combinations of high strength alloys and radiopaque
agents sufficient for this purpose. Components may be selected such
that other endoprosthesis parameters can be optimized, for example,
the strength, stiffness, radiopacity, yield strength, ductility,
magnetic susceptibility, biocompatibility, and the like. Tissue
ingrowth into the endoprosthesis structure can be encouraged.
Tissue ingrowth into a lumen of the endoprosthesis, e.g., a stent
lumen, can be prohibited. Materials having poor solid solubility
may be layered to form an endoprosthesis having a lower risk of
delamination than may be the case absent the first structure.
[0024] Other aspects, features, and advantages will be apparent
from the description of the preferred embodiments thereof and from
the claims.
DESCRIPTION OF DRAWINGS
[0025] FIG. 1 is a perspective view of an embodiment of an expanded
stent.
[0026] FIG. 2 is a cross sectional view of a strut of the stent of
FIG. 1, taken along the line 1-1.
[0027] FIG. 3 is a view of an embodiment of a first structure.
[0028] FIG. 4A is a view of an embodiment of a first structure.
[0029] FIG. 4B is a view of an embodiment of a first structure.
[0030] FIG. 4C is a view of an embodiment of a first structure.
[0031] FIG. 4D is a view of an embodiment of a first structure.
[0032] FIG. 4E is a view of an embodiment of a first structure.
[0033] FIG. 5 is a cross-sectional view of an embodiment of an
endoprosthesis.
[0034] FIG. 6 is a cross-sectional view of an embodiment of an
endoprosthesis.
[0035] FIG. 7 is a flow chart of an embodiment of a method of
making a stent.
[0036] FIG. 8 is an embodiment of a mat overlayed by a layer of
second material.
[0037] FIG. 9 is an embodiment of a mat overlayed by a layer of
second material and a layer of third material.
[0038] FIG. 10 is a schematic for an embodiment of manufacturing of
a composite.
[0039] FIG. 11 is a schematic for an embodiment of manufacturing of
a composite.
[0040] FIG. 12 is a schematic for an embodiment of manufacturing of
a composite.
DETAILED DESCRIPTION
[0041] Referring to FIG. 1, a stent 20 has the form of a tubular
member defined by a plurality of bands 22 and a plurality of
connectors 24 that extend between and connect adjacent bands.
During use, bands 22 may be expanded from an initial, small
diameter to a larger diameter to contact stent 20 against a wall of
a vessel, thereby maintaining the patency of the vessel. Connectors
24 may provide stent 20 with flexibility and conformability that
allow the stent to adapt to the contours of the vessel.
[0042] Referring to FIG. 2, stent 20 includes a composite 26 that
includes a first material 29 and a second material 34 having a
different chemical composition than that of the first material 29.
Composite 26 is made by providing a first structure 28 including
first material 29 and having interconnected portions 31 defining
channels 30, and introducing second material 34 into the channels
30. Second material 34 can wholly or partially fill all or some of
the channels. For example, as illustrated in FIG. 2, second
material 34 fills channels 30 of first structure 28, and extends
around first structure 28 to encapsulate or fully cover the first
structure. Second material 34 may be in at least 50% of the
interconnected channels defined by the first structure (e.g., at
least 60% of the interconnected channels defined by the first
structure, at least 70% of the interconnected channels defined by
the first structure, at least 80% of the interconnected channels
defined by the first structure). Second material 34 is thus in
direct contact with first structure 28 so as to form a bond with
first structure 28. The bond between the first material and the
second material can be a metallurgical bond having a diffusion
layer between the materials, or the bond can be a mechanical bond
without a diffusion layer.
[0043] In some embodiments, at least some of the channels are
interconnected (e.g., at least 25% of the channels are
interconnected, at least 30% of the channels are interconnected, at
least 40% of the channels are interconnected, at least 50% of the
channels are interconnected, at least 60% of the channels are
interconnected, at least 70% of the channels are interconnected, at
least 75% of the channels are interconnected, at least 80% of the
channels are interconnected). The degree of interconnectivity of
the channels can be measured by casting the first structure in
epoxy, grinding the casting down to a planar cross-section,
counting the number of channel intersections that are connected and
not connected, e.g., using microscopy, and converting these values
to a percentage.
[0044] In some embodiments, the interconnecting of channels is such
that, when the channels are filled with second material, the second
material forms a second structure that is interwoven or interlaced
with the first structure. Such interweaving may result in an
enhanced mechanical bond between the first structure and the second
material.
[0045] The composite material is capable of providing
endoprostheses with tailored physical properties (such as density,
stiffness and radiopacity) and/or mechanical properties (such as
yield strength and ductility). For example, a stent made of pure
tantalum can have good biocompatibility and a low magnetic
susceptibility that provides good visualization during magnetic
resonance imaging (MRI). But in some embodiments, a pure tantalum
stent may be too highly radiopaque, and as a result, visualization
of the volume in the stent and of the tissue surrounding the stent
during X-ray fluoroscopy or computed tomography (CT) may be
obscured. To reduce the radiopacity, the stent can be made of a
composite material including a component (e.g., the first
structure, the second material, a third material) including
tantalum and a component including a less dense material, such as
titanium. Since the titanium is less dense than tantalum, the
radiopacity of a sample of the composite is reduced relative to an
otherwise identical sample of tantalum. At the same time, since
titanium also has good biocompatibility and a low magnetic
susceptibility, the composite also has good biocompatibility and
MRI compatibility. Further, since titanium has high yield strength,
the composite has increased strength relative to tantalum alone.
Other high density materials, such as molybdenum, niobium,
platinum, and their alloys, can be similarly modified as described
above for tantalum. Reducing the radiopacity may be particularly
beneficial for thick walled stents (such as peripheral vascular
stents). As another example, the composite can also be used to
increase the radiopacity of an endoprosthesis, such as by combining
a component including tantalum particles with a Nitinol component.
Increasing the radiopacity may be particularly beneficial for thin
walled stents and may obviate the need for radiopaque markers on
stents. When combining such components, either the first or the
second material may be utilized to enhance any desired property.
For example, either the first material or the second material can
be selected to enhance the strength of the device or to enhance the
radiopacity of the device.
[0046] The materials can also be selected so as to enhance the
mechanical properties of the device. Without wishing to be bound by
theory, it is believed that one component can be selected to
increase the stiffness (tensile modulus) and/or strength (yield
strength) of the composite (as compared against the strength of a
similar device made only of the other material). For example,
tantalum, tungsten, and/or rhenium can increase the stiffness of
component including titanium or niobium, as compared against pure
titanium or niobium. The enhanced mechanical properties may allow
the stent to be formed with reduced wall thickness without
compromising the performance of the stent. A thinner walled stent
may be more easily delivered through a tortuous path, may be
implanted in a smaller bodily vessel, and may allow more fluid flow
through the stent.
[0047] The first structure in some embodiments includes (e.g., is
manufactured from) a first material that itself can include one or
more biocompatible materials with mechanical properties that allow
an endoprosthesis including composite material to be compacted, and
subsequently expanded to support a vessel. In some embodiments, the
endoprosthesis material can have an ultimate tensile strength (UTS)
of about 20-150 ksi, greater than about 10% elongation to failure,
and a modulus of elasticity of about 10-60 msi. When the
endoprosthesis is expanded, the material can be stretched to
strains on the order of about 0.6. Examples of first materials for
the first structure include stainless steel (e.g., 316L and 304L
stainless steel, and an alloy including stainless steel and 5-60%
by weight of one or more radiopaque elements (e.g., Pt, Ir, Au, W)
(PERSS.RTM.) as described in US-2003-0018380-A1,
US-2002-0144757-A1, and US-2003-0077200-A1), Nitinol (a
nickel-titanium alloy), Elgiloy, L605 alloys, MP35N, titanium,
titanium alloys (e.g., Ti-6Al-4V, Ti-50Ta, Ti-10Ir), platinum,
platinum alloys, chromium, chromium alloys, molybdenum, molybdenum
alloys, niobium, niobium alloys (e.g., Nb-1Zr), Co-28Cr-6Mo,
tantalum, and tantalum alloys. Other examples of materials are
described in commonly assigned U.S. Ser. No. 10/672,891, filed Sep.
26, 2993, and entitled "Medical Devices and Methods of Making
Same"; and U.S. Ser. No. 11/035,316, filed Jan. 3, 2005, and
entitled "Medical Devices and Methods of Making Same". Other
materials include elastic biocompatible metal such as a
superelastic or pseudo-elastic metal alloy, as described, for
example, in Schetsky, L. McDonald, "Shape Memory Alloys",
Encyclopedia of Chemical Technology (3rd ed.), John Wiley &
Sons, 1982, vol. 20. pp. 726-736; and commonly assigned U.S. Ser.
No. 10/346,487, filed Jan. 17, 2003.
[0048] In some embodiments, the first structure includes one or
more materials that enhance visibility by MRI. Examples of MRI
materials include non-ferrous metals (e.g., copper, silver,
platinum, or gold) and non-ferrous metal-alloys containing
paramagnetic elements (e.g., dysprosium or gadolinium) such as
terbium-dysprosium, dysprosium, and gadolinium. Alternatively or
additionally, the first structure can include one or more materials
having low magnetic susceptibility to reduce magnetic
susceptibility artifacts, which during imaging can interfere with
imaging of tissue, e.g., adjacent to and/or surrounding the stent.
Low magnetic susceptibility materials include those described
above, such as tantalum, platinum, titanium, niobium, copper,
chromium, molybdenum, and alloys containing one or more of these
elements.
[0049] The second material in some embodiments can include one or
more biocompatible materials, for example, those described above
with regard to the first structure, provided the chemical
composition(s) of the first material is different from the chemical
composition(s) of the second material. In embodiments in which the
second material includes one or more radiopaque materials to
enhance radiopacity, the particles may include metallic elements
having atomic numbers greater than 26 (e.g., greater than 43),
and/or a density greater than about 9.9 g/cc. In certain
embodiments, the radiopaque material is relatively absorptive of
X-rays, e.g., having a linear attenuation coefficient of at least
25 cm.sup.-1, e.g., at least 50 cm.sup.-1, at 100 keV. Some
radiopaque materials include tantalum, platinum, iridium,
palladium, hafnium, tungsten, gold, ruthenium, and rhenium. The
radiopaque material can include an alloy, such as a binary, a
ternary or more complex alloy, containing one or more elements
listed above with one or more other elements such as iron, nickel,
cobalt, or titanium. Examples of alloys including one or more
radiopaque materials are described in U.S. Application Publication
US-2003-0018380-A1; US-2002-0144757-A1; and US-2003-0077200-A1.
Alternatively or additionally, in embodiments in which the second
material includes one or more components or materials to enhance
MRI visibility, the second material may include an oxide or a
carbide layer of dysprosium or gadolinium (e.g., Dy.sub.2O.sub.3 or
Gd.sub.2O.sub.3); a superparamagnetic material, such as
Fe.sub.3O.sub.4, CoFe.sub.2O.sub.4, MnFe.sub.2O.sub.4, or
MgFe.sub.2O.sub.4; and/or transition metal oxides (e.g., oxides of
Fe, Co, Ni). Thus, the chemical composition of the second material
need not be limited to metallic materials (e.g., metal and alloys),
but the particles may include non-metallic compounds, such as
ceramics, for example, oxides (e.g., aluminum oxide), carbides
(e.g., silicon carbide), and nitrides (e.g., titanium nitrides), as
further illustrated by the exemplary materials listed above.
[0050] The relative quantities of first material and second
material in the composite can vary depending on the particular
materials utilized and the endoprosthesis parameter or parameters
sought. For example, a composite may incorporate between about 1
and about 50 volume percent of a radiopaque material where
radiopacity is sought. In certain embodiments, the radiopaque
material is a high density material, e.g., platinum, that typically
need be present in lower amounts, e.g., between about 1 and about
30 volume percent. In certain embodiments, the radiopaque material
is a lower density material, for example, niobium, and is present
in somewhat higher amounts, e.g., between about 20 and about 50
volume percent.
[0051] As another example, a composite may include a material
designed to increase the stiffness of the endoprosthesis at between
about 20 and about 80 volume percent. For example, stainless steel,
which has stiffness similar to current stents, can be incorporated
at between, e.g., about 60 and about 80 volume percent, whereas a
material having a high modulus, e.g., iridium, can be included in
amounts ranging, e.g., from about 20 to about 40 volume
percent.
[0052] As another example, a composite may include a material
designed to increase the yield strength of the composite at between
about 20 and about 80 volume percent. For example, stainless steel,
which has a yield strength similar to current stents, can be
incorporated at between, e.g., about 60 and about 80 volume
percent, whereas a material having a high yield strength, e.g.,
Ti-6Al-4V, can be included in amounts ranging, e.g., from about 20
to about 40 volume percent.
[0053] FIG. 3 shows a three-dimensional view of an embodiment of a
first structure 40 absent any second material. In this embodiment,
the first structure 40 is made up of a series of interconnected
portions 42 that define interconnected channels 44. For example, a
first channel and a second channel may be connected together to
define a plane, and at least one other channel (at least two
channels, at least three channels, at least four channels, at least
five channels) may be directly connected to the first channel or
the second channel and extend transversely to the plane. At least
some of the channels may be interconnected to more than one channel
(e.g., may be interconnected to at least two channels, at least
three channels, at least four channels, at least five channels),
and may be connected to multiple channels extending in at least two
different directions (e.g., at least three different directions, at
least four different directions, at least five different
directions).
[0054] Substantially all (for example, 80%, 90%, 95%) of the
channels 44 are interconnected to each other. Further,
substantially all of the channels defined by the interconnected
portions of the first structure may be connected to at least one
channel that is open to the exterior of the first structure, not
illustrated, to permit or facilitate the filling of the open
volumes with second (or third, fourth, etc.) material as discussed
further below. In some embodiments, the majority of the channels
are themselves open to the exterior of the first structure, for
example, 50% of the channels are open to the exterior of the first
structure, 75% of the channels are open to the exterior of the
first structure, 80% of the channels are open to the exterior of
the first structure, 90% of the channels are open to the exterior
of the first structure, 95% of the channels are open to the
exterior of the first structure.
[0055] FIGS. 4A-4E show certain embodiments of the first structure.
FIG. 4A shows a foam, which can be, for example, a Trabecular
Metal.TM. foam (a material composed of tantalum on a graphite
scaffold) in which channels interconnect with each other in a
three-dimensional fashion. FIG. 4B shows a single layer of a wire
weave mesh; typically, at least two such layers are be overlaid to
form a three-dimensional network of interconnected channels. A
single layer of a braided wire is illustrated in FIG. 4C; again,
braided wires are typically arranged to provide a three-dimensional
network of interconnected channels by, or example, overlaying at
least two such layers. FIG. 4D shows a tangled wire having a
three-dimensional network of interconnected channels. FIG. 4E shows
a single layer of a honeycomb structure, which may also typically
be arranged to provide a three-dimensional network of
interconnected channels. Forms employing combinations of these are
also possible. The first structure may also utilize any other form
having a substantially continuous structure defining interconnected
channels, or any combination of such forms.
[0056] An embodiment of an endoprosthesis is illustrated in FIG. 5.
Generally cylindrical endoprosthesis 100 includes a first portion
102 which makes up the interior portion of endoprosthesis 100 and a
second portion 104 which makes up the outer portion of
endoprosthesis 100. The endoprosthesis can be separated into first
and second portions longitudinally rather than axially, and can
include additional sections. Endoprosthesis 100 is made up of
composite 106 which includes a first structure 107 having portions
108, 109, extending into both the first portion 102 and the second
portion 104 of the endoprosthesis, respectively. First structure
108 includes interconnected portions 110, 112 that define channels
114, which are open to the exterior of the first structure. Second
material 120 is in the channels of the portion 108 of first
structure 107 that extends into the first portion 102 of
endoprosthesis 100. A layer 122 of second material 120 also
encapsulates the interior-facing surface of the portion 108 of
first structure 107 that extends into the first portion of the
endoprosthesis. Channels of the portion 109 of first structure 107
that extends into the second portion 104 of the endoprosthesis
remain substantially open or unfilled. Such open channels may
encourage tissue ingrowth once the endoprosthesis has been
implanted or deployed, which may advantageously stabilize the
endoprosthesis in vivo. The layer of second material may serve as a
barrier to prevent further tissue ingrowth into the lumen of the
endoprosthesis.
[0057] Another embodiment is illustrated in FIG. 6, in which a
generally cylindrical endoprosthesis 200 includes a first portion
202 which makes up the interior portion of the endoprosthesis and a
second portion 204 which makes up the outer portion of the
endoprosthesis. Endoprosthesis 200 includes composite 206 which has
a first structure 207 having portions 208, 209, extending into both
the first portion 202 and the second portion 204 of the
endoprosthesis, respectively. First structure 208 includes
interconnected portions 210, 212 that define interconnected
channels 214, which are open to the exterior of the first
structure. Second material 220 is in the channels 214 of the
portion 208 of first structure 207 that extends into the first
portion 202 of endoprosthesis 200. A layer 222 of second material
220 also encapsulates the interior-facing surface of the portion
208 of first structure 207 that extends into the first portion of
the endoprosthesis. A third material 230 is in the channels 214 of
the portion 209 of the first structure 207 that extends into the
second portion 204 of endoprosthesis 200. A layer 232 of third
material encapsulates the exterior-facing surface of the portion
209 of first structure 207 that extends into the second portion 204
of endoprosthesis 200. Such a design may allow a first structure
comprised of a material which does not have proven biocompatibility
to be utilized by permitting the unproven material to be fully
encapsulated with second and third material, each of which may be
biocompatible, thus rendering the endoprosthesis biocompatible.
Without permanent and complete encapsulation, only biocompatible
materials with long, successful implant clinical experience are
typically used. With the encapsulation, materials with unique
properties but without implant clinical experience can be used
(e.g., copper for MRI magnetic susceptibility compatibility, silver
for MRI magnetic susceptibility compatibility and radiopacity
enhancement, tungsten for high stiffness and radiopacity
enhancement). In some embodiments, one or more of the first, second
and third materials may be biodegradable and/or bioabsorbable. Such
may allow for encapsulation of the endoprosthesis, for example,
with a layer of biodegradable third material to provide a smooth
outer endoprosthesis surface, which may reduce or prevent damage to
the lumen through which it is passed prior to deployment, while
also allowing for the channels of the first structure that are open
to the exterior of the endoprosthesis to become exposed and empty,
allowing for tissue ingrowth as described above.
[0058] FIG. 7 shows a method 340 of making stent 20. As shown,
method 340 includes forming a composite (step 342) and using the
composite to form a tube (step 344) that makes up the tubular
member of stent 20. The tube is subsequently cut to form bands 22
and connectors 24 (step 346) to produce an unfinished stent. Areas
of the unfinished stent affected by the cutting may be subsequently
removed (step 348). The unfinished stent may be finished to form
stent 20 (step 350).
[0059] The steps of forming the composite (step 342) and of using
the composite to form a tube (step 344) can optionally take place
as a single step, in which the composite is formed in the shape of
a tube as the composite is put together. Also, the steps of cutting
the tube and removing the cut affected areas may be eliminated, for
example, where the composite is formed in the final shape or form
of the endoprosthesis (e.g., is formed in a stent-shaped mold).
[0060] In certain embodiments, a first structure is formed as an
initial step. The first structure in certain embodiments is made by
vacuum plasma spray deposition in which the structural metal in
powder form is passed through a plasma torch and the droplets splat
down onto a substrate. The porosity level in the deposit can be
controlled by the powder particle size, gas flow rate into the
nozzle, and impingement angle of the spray plume upon the
substrate. The porous deposit can be built up to significant
thicknesses if desired (e.g., up to one inch thick).
[0061] In certain embodiments, a wire mesh first structure is made
by weaving or braiding individual wires to form a gridwork pattern.
The interstitial open space within the braid or weave can be
controlled by the number of wires used (more wires leave smaller
openings), the thickness of the wire used, and the number of
crossover points. Wires can be chopped into short fibers and
tumbled, causing them to bend about each other to form an
entanglement. The tangled wires can be mechanically attached to
each other, leaving open spaces between the wires. In certain
embodiments, metal rings with a spiral, "S"-shaped, "C"-shaped or
hook-shape can be interlocked to form a tangled metal structure,
either in place of or in conjunction with the use of wires. The
rings can be formed of chopped tubing or can be produced from
sheet/foil that has been cut and mechanically formed. Metal
turnings can be machined off of a bar or plate. Turning size can be
tailored by the dimensions of the bar and/or the dimensions of the
tooling used during machining and/or the amount of material
removed. The shapes can be mechanically combined (tangled) by
shaking, vibrating, tumbling, or hand or machine assembly. The
preforms made by this technique can be chains, agglomerates,
bunches, or bricks.
[0062] In certain embodiments, a first structure in the form of a
honeycomb is formed by making holes in a flat strip of material,
e.g., by drilling or chemical machining. The flat strips can
optionally be made to be wavy or rippled, e.g., using metal press
forming equipment. The formed strips can then be brazed, welded, or
mechanically attached together to form a honeycomb structure.
[0063] Instead of using wires to make a tangled wire structure,
metal rings with a spiral, "S"-shaped, "C"-shaped or hook-shape can
be interlocked to form a tangled metal structure. They can be from
chopped tubing or from sheet/foil that has been cut and
mechanically formed. Metal turnings can be machined off of a bar or
plate. Turning size can be tailored by the amount of material
removed and/or the dimensions of the bar and/or the dimensions of
the tooling used during machining. The shapes can be mechanically
combined (tangled) by shaking, vibrating, tumbling, or hand
assembly. The preforms made by this technique can be chains,
agglomerates, bunches, or bricks.
[0064] The composite formed in step 342 includes a first structure
comprising a first material and having interconnected portions that
define interconnected channels, and a second material located in at
least some of the channels, wherein the first material and second
material have different chemical compositions. In some embodiments,
for example, the embodiment illustrated in FIG. 10, a dry composite
365 is formed by placing a first structure 362 into a metal can 364
and introducing a second material 360 in powdered form into the can
364 to fill at least some of the channels in the first structure
362. The dry composite 365 is then densified, consolidated or
compressed under pressure to form a composite 366. The second
material has a powder particle size smaller than the minimum width
of the channels (e.g., no more than about 300 microns, no more than
about 100 microns, no more than about 50 microns, no more than
about 10 microns) to permit the material to enter and move through
the channels. Optionally, the first structure is agitated, e.g.,
shaken, vibrated or centrifugally rotated, during or subsequent to
introduction of the powdered second material to assist with
introduction of and distribution of the powder throughout the first
structure. Consolidation of the dry composite may be performed by
cold pressing, sintering, or diffusion bonding, e.g., hot isostatic
pressing, the dry composite. Such consolidation may pack the
materials into denser masses, for example, may consolidate the dry
composite into a component approaching 100% theoretical density.
The composite 366 is then milled or machined to form a billet
368.
[0065] The composite preform need not be fully dense, such as, for
example, if it is to be processed by additional shapeforming
operations that will increase density. For example, a preform that
is 50% or more dense can be hot extruded or hot bar rolled to
decrease diameter and increase length; the compressive forming may
close the voids in the composite and increase the density. In some
embodiments, the final endoprosthesis may have a density less than
about 100% theoretical density (e.g., less than about 99%
theoretical density, less than about 95% theoretical density, less
than about 90% theoretical density, less than about 85% theoretical
density, or less than about 80% theoretical density). An
endoprosthesis having a density below about 100% theoretical
density may have porosity that can be utilized, for example, for
carrying therapeutic agents or can be utilized to facilitate
implant anchoring via tissue ingrowth. For example, a stent with a
solid, continuous strut inner surface and a porous (less than about
100% theoretical density) strut outer surface may allow tissue to
grow into the stent structure to facilitate anchoring of the strut,
while not allowing tissue ingrowth through the stent struts and
into the lumen. The porous outer strut material is in certain
embodiments infiltrated with a substance that may promote fast
tissue ingrowth so that the stent can be expanded into the vessel
wall with less pressure and less injury, as some of the anchoring
may be accomplished by rapid tissue ingrowth into the porous outer
material.
[0066] In certain embodiments, molten second material is introduced
into at least some of the channels in the first structure to form
the composite. For example, in the method illustrated in FIG. 11, a
first structure 362 is placed into a ceramic mold 372, and molten
second material 370 is poured into the mold to impregnate the
channels in the first structure 362 and form the composite 378. A
gap 374 exists between the first structure 362 and the interior
walls of the ceramic mold 372 to permit the molten second material
372 to cover the exterior of and encapsulate the first structure
362. The second material may be melted by vacuum induction skull
method, which allows the molten alloy to be contained within a thin
solid shell of the same composition, which can be advantageous when
the alloy is highly reactive, e.g., titanium. The second material
may optionally have a lower melting temperature than the first
material, e.g., the second material may be titanium (which has a
melting point of 1660.degree. C.) and the first structure may be
tantalum (which has a melting point of 2996.degree. C.). The first
structure may be placed in a mold, and second material may be
introduced to the mold and allowed to flow into at least some of
the channels in the first structure, optionally with the aid of
pressure. The first structure may be positioned in the mold such
that some or all of the exterior surfaces of the first structure
are covered by or encapsulated with second material. Optionally,
the molten second material may be introduced into at least some of
the channels in the first structure by introducing, e.g., dipping,
the first structure may into molten second material, or by vacuum
plasma spraying the molten second material into the first
structure, either of which does not require a mold.
[0067] In certain embodiments, as illustrated in FIG. 12, the
composite is formed by creating a mold out of second material, the
mold having hollow passages in the shape of the first structure,
and introducing molten first material into the hollow passages,
again optionally with the aid of pressure. A core structure 380,
having the form desired for the first structure, is placed in a
container 381. Molten second material 382 is introduced into the
container and allowed to harden. The core structure 380 is then
removed, leaving a hardened second material mold 383 having hollow
channels or passages 385 where the core structure had been. The
channels have at least one opening 386 at a face of hardened second
material mold 383 into which a molten first material 387 is
introduced forming a composite 388. The first material 387 is
allowed to cool and harden. The core structure 380 is made of
material that can be removed from the second material, for example,
by ashing, leaching, dissolving or the like (e.g., a ceramic which
may be removed from the second material, for example, by leaching).
The core structure extends to the edge of the mold in at least one
location to provide an exposed or open channel, upon having removed
the core structure, to permit introduction of first material. A
third material having a different chemical composition than the
second material can be incorporated, either as a part of the mold
or as a part of the first structure. The first material may be
added as a powder rather than in molten form in a fashion similar
to that described above.
[0068] In some embodiments, for example those illustrated in FIG.
8, the composite is made from a first material having a first
structure in the form of a mat 302. The mat 302 is overlayed with a
layer of second material 304, and the mat and the second material
are bonded, for example, by annealing or diffusion bonding, such
that at least some second material enters at least one channel 305
in the mat 302. As illustrated in FIG. 9, a layer of third material
306 may also be included, which may overlay a side of the mat
opposite that of the layer of second material. Such a third
material may have a different chemical composition than the second
material, the first material, or both. In such a fashion, an
endoprosthesis, e.g., a stent, can be formed having different
materials on first and second portions of the stent, for example,
on an outer portion of the stent and an inner portion of the stent.
This allows for the formation of an endoprosthesis having different
materials at the exterior surface and interior surface mechanically
and/or metallurgically held together where such materials exhibit
poor solid solubility with each other or are difficult to process
into single-phase, homogeneous solid solutions with each other such
that they may risk delamination absent the first structure. For
example, tantalum and titanium typically are not alloyed at more
than a couple weight percent with austenitic stainless steel, such
as 316L, because these elements are not austenite phase
stabilizers; other phases such as ferrite or martensite can form in
the titanium or tantalum-bearing alloy which can render the alloy
more magnetic than 316L, thereby posing a safety risk with MRI. As
another example, it may be desirable to combine iridium with
titanium to increase the relatively low radiopacity and modulus of
titanium, however, only up to about 10 atomic percent iridium,
likely not enough to significantly enhance the radiopacity and
modulus of the alloy over that of pure titanium, can be added to
titanium without forming brittle intermetallic phases. As yet
another example, tantalum and titanium are difficult to alloy
together by melting, because the melting temperature for tantalum
is much higher than for titanium. The titanium may tend to solidify
before the tantalum, resulting in significant chemical
heterogeneity in the ingot. This can lead to tearing during forming
and non-uniform mechanical properties in the final
endoprosthesis.
[0069] In certain embodiments, the third material may be the same
as the second material, for example, to permit the formation of a
stent that is fully encapsulated by a second material. In a similar
fashion, bands of second and third material can be overlayed on the
mat to provide an endoprosthesis having different composites
longitudinally. Such may allow, for example, for the inclusion of a
band of material exhibiting desired RO properties to act as a
radiopaque marker on the endoprosthesis. Similarly, the first
structure can include discrete layers of first material and an
additional material differing in chemical structure from the first
material.
[0070] In some embodiments, a layer of second material can have a
first structure imposed upon a surface by vapor deposition. For
example, a thin-walled stent tube made up of second material can be
drawn and used as a solid inner layer of a stent, and a first
structure can be grown on the exterior layer to form the first
structure
[0071] After the composite is formed, it is formed into a tube
(step 344). In some embodiments, a billet is created from the
composite, for example, by cold isostatic pressure, hot isostatic
pressure, or sintering of the composite. The billet may then be
formed into a rod shape, for example, by hot extrusion or hot
rolling of the billet. The rod may then be gun drilled, that is,
have a bore drilled longitudinally down the center of the rod, to
form a hollow rod, which may then be drawn, e.g., cold drawn, to
form tubing in about the desired configuration for the prosthesis.
Alternately, metal injection molding can be used to produce bar,
tubing, or stent tubing blanks at near net size.
[0072] Alternatively or additionally, other thermomechanical
processes can also be used to form a tubular member made of a
mechanical composite material. For example, the second material
need not be molten to form the composite material. The second
material and the first structure can be combined by powder
metallurgy techniques (such as pressure casting, sintering, hot
isostatic pressing, and hot working), slurry mixing, direct laser
sintering, and vacuum plasma deposition, to form a raw material
that is subsequently shaped into a feedstock, such as a hollow
tubular member. A medical device including a composite material
having variable concentrations of first and second (and, where
applicable, third, fourth, etc.) materials can be made by joining
multiple portions (e.g., billets) of composites having different
concentrations by sintering. Endoprostheses, e.g. stents, with
layers of composite of different concentrations can be formed by
sequentially adding the selected composites into a mold to form the
tubular member.
[0073] In some embodiments, the hollow tubular member including the
composite can be drawn through a series of dies with progressively
smaller circular openings to plastically deform the member to a
targeted size and shape. The plastic deformation strain can harden
the member (and increases its yield strength) and elongate grains
of some or all materials used to form the composite along the
longitudinal axis of the member. The deformed member can be heat
treated (e.g., annealed above the recrystallization temperature
and/or hot isostatically pressed) to transform the elongated grain
structure into an initial grain structure, e.g., one including
equiaxed grains. Small or fine grains can be formed by heating the
member close to the recrystallization temperature for a short time.
Large or coarse grains can be formed by heating the member at
higher temperatures and/or for longer times to promote grain
growth.
[0074] Once in tubing form, bands 22 and connectors 24 of stent 20
are formed, as shown, by cutting the tube (step 346). Selected
portions of the tube can be removed to form bands 22 and connectors
24 by laser cutting, as described in U.S. Pat. No. 5,780,807,
hereby incorporated by reference in its entirety. In certain
embodiments, during laser cutting, a liquid carrier, such as a
solvent or an oil, is flowed through the lumen of the tube. The
carrier can prevent dross formed on one portion of the tube from
re-depositing on another portion, and/or reduce formation of recast
material on the tube. Other methods of removing portions of the
tube can be used, such as mechanical machining (e.g.,
micro-machining), electrical discharge machining (EDM), and
photoetching (e.g., acid photoetching).
[0075] In some embodiments, after bands 22 and connectors 24 are
formed, areas of the tube affected by the cutting operation above
can be removed (step 348). For example, laser machining of bands 22
and connectors 24 can leave a surface layer of melted and
resolidified material and/or oxidized metal that can adversely
affect the mechanical properties and performance of stent 20. The
affected areas can be removed mechanically (such as by grit
blasting or honing) and/or chemically (such as by etching or
electropolishing). In some embodiments, the tubular member can be
near net shape configuration after step 348 is performed. "Near-net
size" means that the tube has a relatively thin envelope of
material that is removed to provide a finished stent. In some
embodiments, the tube is formed less than about 25% oversized,
e.g., less than about 15%, 10%, or 5% oversized.
[0076] The unfinished stent is then finished to form stent 20 (step
350). The unfinished stent can be finished, for example, by
electropolishing to a smooth finish. Since the unfinished stent can
be formed to near-net size, relatively little of the unfinished
stent need to be removed to finish the stent. As a result, further
processing (which can damage the stent) and costly materials can be
reduced. In some embodiments, about 0.0001 inch of the stent
material can be removed by chemical milling and/or electropolishing
to yield a stent.
[0077] Stent 20 can be of a desired shape and size (e.g., coronary
stents, aortic stents, peripheral vascular stents, gastrointestinal
stents, urology stents, and neurology stents). Depending on the
application, stent 20 can have a diameter of between, for example,
1 mm to 46 mm. In certain embodiments, a coronary stent can have an
expanded diameter of from about 2 mm to about 6 mm. In some
embodiments, a peripheral stent can have an expanded diameter of
from about 5 mm to about 24 mm. In certain embodiments, a
gastrointestinal and/or urology stent can have an expanded diameter
of from about 6 mm to about 30 mm. In some embodiments, a neurology
stent can have an expanded diameter of from about 1 mm to about 12
mm. An abdominal aortic aneurysm (AAA) stent and a thoracic aortic
aneurysm (TAA) stent can have a diameter from about 20 mm to about
46 mm. Stent 20 can be balloon-expandable, self-expandable, or a
combination of both (e.g., U.S. Pat. No. 5,366,504).
[0078] In use, stent 20 can be used, e.g., delivered and expanded,
using a catheter delivery system. Catheter systems are described
in, for example, Wang U.S. Pat. No. 5,195,969, Hamlin U.S. Pat. No.
5,270,086, and Raeder-Devens, U.S. Pat. No. 6,726,712. Stents and
stent delivery are also exemplified by the Radius.RTM. or
Symbiot.RTM. systems, available from Boston Scientific Scimed,
Maple Grove, Minn.
[0079] While a number of embodiments have been described above, the
invention is not so limited.
[0080] As an example, while stent 20 is shown above as being formed
wholly of composite 26, in other embodiments, the composite forms
one or more selected portions of the medical device. For example,
stent 20 can include multiple layers in which one or more layers
include a composite, and one or more layers do not include a
composite. The layer(s) that includes a composite can include the
same composite materials or different composite materials. The
layer(s) that does not include a composite may include one or more
of the biocompatible materials listed above. The layering of the
composite material provides yet another way to tailor and tune the
properties of the medical device. Stents including multiple layers
are described, for example, in published patent application
2004-0044397, and Heath, U.S. Pat. No. 6,287,331.
[0081] Stent 20 can be a part of a covered stent or a stent-graft.
In other embodiments, stent 20 can include and/or be attached to a
biocompatible, non-porous or semi-porous polymer matrix made of
polytetrafluoroethylene (PTFE), expanded PTFE, polyethylene,
urethane, or polypropylene.
[0082] Stent 20 can include a releasable therapeutic agent, drug,
or a pharmaceutically active compound, such as described in U.S.
Pat. No. 5,674,242, U.S. Ser. No. 09/895,415, filed Jul. 2, 2001,
and U.S. Ser. No. 10/232,265, filed Aug. 30, 2002. The therapeutic
agents, drugs, or pharmaceutically active compounds can include,
for example, anti-thrombogenic agents, antioxidants,
anti-inflammatory agents, anesthetic agents, anti-coagulants, and
antibiotics.
[0083] In some embodiments, stent 20 can be formed by fabricating a
wire including the composite, and knitting and/or weaving the wire
into a tubular member.
[0084] The endoprosthesis may include a plurality of composites
having different compositions.
[0085] The following examples are illustrative and not intended to
be limiting.
Example 1
[0086] A titanium matrix can be cast about a tantalum porous
structure. Tantalum wire mesh such as Goodfellow (Huntingdon,
England), part number TA008710 (order code 349-745-35), with a
nominal wire diameter of 0.075 mm and 72% open area, can be stacked
to form an assembly that is about 1 mm thick. The assembly can be
suspended in the middle of a 3 mm cavity in a ceramic mold.
Titanium can be melted via e-beam, plasma, or induction skull
melting and poured into the mold. Since the titanium melts at 1668
C and the tantalum melts at 2996 C, the tantalum will remain solid
as the liquid titanium flows into the open areas of the mesh and
encapsulates the tantalum mesh assembly. After solidification and
cooling, the ceramic mold can be dissolved or broken away from the
metal casting. The three mm-thick casting can be canned
(encapsulated) with steel or stainless steel, evacuated, and
sealed. The container can be hot isostatically pressed at 2150 F
for 8 hours in order to density the casting. The hot isostatically
pressed casting can then be hot or cold rolled with interpass
anneals at 700 C to a thickness of 0.10 mm. The strip can then be
rolled into a tube and TIG seam welded. The welded tube can then be
mandrel drawn to 0.072 outer diameter and 0.075 mm wall thickness
to cold work the weld thereby making the weld stronger. A coronary
stent can be cut from the drawn or heat treated tube using laser
machining technique. The cut stent can be electropolished to final
dimensions and surface finish. The result will be a stent with a
surface consisting primarily of titanium and with some
intersections of tantalum from the core to the surface and a core
of tantalum lacing through the titanium matrix. The tantalum will
provide radiopacity and stiffness enhancement, since it has higher
density and modulus than titanium, and the stent will have high
compression resistance than a comparable stent formed of pure
talantum, because titanium has a higher strength than tantalum.
Example 2
[0087] Alternate layers of tantalum mesh from the previous example
and 1 mm thick Ti 6A1-4V foil (Goodfellow TI010500) can be
overlayed until the assembly is about 10 mm thick, with the bottom
and top layers being titanium alloy foil. Two additional layers of
the titanium alloy foil can then be added to the top and bottom of
the stack. The titanium layers should extend out 25 mm beyond all
tantalum mesh edges. The edges of the titanium layers can be tack
welded to hold the stack together. The stack can then be hot or
cold pressed to achieve a 50-70% reduction in thickness. The
pressed preform can then be alternately cold rolled and annealed
until a thickness of 0.10 mm is achieved. The strip can then be
rolled into a tube and seam welded. The welded tube can then be
mandrel drawn to 0.075 mm wall thickness. A stent can be cut from
the drawn or heat treated tube using laser machining technique. The
cut stent can be electropolished to final dimensions and surface
finish. The result will be a stent with a surface consisting
primarily of titanium and with some intersections of tantalum from
the core to the surface and a core of tantalum lacing through the
titanium matrix.
Example 3
[0088] A tantalum wire mesh assembly, e.g., as in the first two
examples, can be placed within a tubular ceramic mold and cast with
titanium or interlayered between coaxial titanium tubes such that
cylindrical preforms can be made. The preforms may then be mandrel
or floating plug tube drawn with interpass anneals to form stent
tubing.
[0089] All publications, references, applications, and patents
referred to herein are incorporated by reference in their
entirety.
[0090] Other embodiments are within the claims.
* * * * *